Utah Cancer Specialists

Salt Lake City, Utah 84106

Use our guide to learn which trials are right for you!

We've found
15 trials
at this facility
Oncology Clinical Trial
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Status: Enrolling, Phase II
Updated: 9/3/2014
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Metastatic Castrate Resistant Prostate Cancer Clinical Trial
Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/5/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
HER2+ Metastatic Breast Cancer (MBC) Clinical Trial
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
Status: Enrolling, Phase III
Updated: 3/28/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Soft Tissue Sarcoma Clinical Trial
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Status: Enrolling, Phase III
Updated: 2/19/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Myelogenous Leukemia, Chronic Clinical Trial
A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Status: Enrolling
Updated: 7/18/2012
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Indolent Non-Hodgkins Lymphomas Clinical Trial
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Status: Enrolling, Phase III
Updated: 3/3/2015
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Soft Tissue Sarcoma Clinical Trial
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Status: Enrolling, Phase I, II
Updated: 3/10/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 3/10/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Efficacy and Safety of Idelalisib (GS-1101; CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 2/21/2014
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Metastatic Renal Cell Carcinoma Clinical Trial
CRLX101 in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)
Status: Enrolling, Phase II
Updated: 1/5/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/14/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 2/19/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 3/21/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials